ERS Highlights

Michael Wechsler, ERS 2020 – Dupilumab in the LIBERTY ASTHMA TRAVERSE Trial

We discuss with Michael Wechsler (National Jewish Health, Denver, CO, USA) the clinical evidence supporting the use of dupilumab in patients with asthma and specifically the major findings from the long-term safety evaluation of dupilumab in the LIBERTY ASTHMA TRAVERSE trial (NCT02134028). Questions 1. What are the major unmet needs in the biologic treatment of […]

COVID-19

Ivan Gentile, ERS 2020 – Outcome Prediction in COVID-19 Patients

Following the ERS International Congress, we were delighted to catch up with Prof. Ivan Gentile to further discuss the topic of his presentation entitled ‘Severity Assessment and Outcome Prediction in COVID-19 Patients‘. Questions 1. Why do levels of C-reactive protein (CRP) increase during COVID-19? (0:20) 2. How can CRP testing inform severity assessment and outcome […]

COVID-19

Sara De Matteis, ERS 2020 – Air Pollution and COVID-19 Mortality

We discuss with Prof. Sara De Matteis (University of Cagliari, Cagliari, Italy) what we know so far about the potential association between air pollution exposure and SARS-CoV-2 infection. Questions 1. Could you give us a brief overview of the potential association between air pollution exposure and SARS-CoV-2 infection? (0:34) 2. What is the biological plausibility […]

COVID-19

Filippos Filippidis, ERS 2020 – Smoking as a Risk Factor for COVID-19 Infection and Severe Disease

We discuss with Dr. Filippos Filippids (Imperial College London, London, UK) what the literature has shown us so far about the link between smoking and COVID-19 disease. Questions 1. What do we know so far about COVID-19 and smoking? (0:10) 2. What are the current challenges and limitations of research into the impact of smoking […]

Asthma

Richard van Zyl-Smit, ERS 2020 – Optimising Inhaled Therapies for Asthma

Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field. Questions What are the major unmet needs in the use of inhaled therapies for the control of […]

Sarcoidosis

Vasileios Kouranos, ERS 2020 – Management of Cardiac Sarcoidosis

We were delighted to discuss with Vasileios Kouranos (Royal Brompton Hospital, London, UK) the current unmet need in the treatment of pulmonary and cardiac sarcoidosis alongside the therapeutic advances being made. Questions Could you give us a brief overview of pulmonary and cardiac sarcoidosis, their prevalence and prognosis? (0:22) What are the major unmet needs […]

Asthma, COPD

Peter J Barnes, ERS 2020 – Smart Inhalers for COPD and Asthma

During the ERS International Congress 2020, it was great to catch up with our Editorial Board member, Prof. Peter J Barnes (Imperial College, London, UK), to continue the discussion around Smart Inhalers and how they could help optimise inhaler use in patients. Questions How common is poor adherence and inhaler technique in people with asthma […]

Asthma

Liam Heaney, ERS 2020 – Corticosteroid Optimisation using Composite Biomarkers

Following his recent publication in the Lancet Respiratory Medicine, and presentation at the ERS Congress, we spoke with Prof. Liam Heaney (Queen’s University, Belfast, Northern Ireland, UK) about the composite biomarker approach to optimising steroid dosage in patients with severe asthma. Questions Why is there a need for new approaches to optimising steroid dosage in people […]

COVID-19

Tobias Welte, ERS 2020 – COVID-19 Vaccines and Early Trials

It was a pleasure to meet with Prof. Tobias Welte (Medizinische Hochschule, Hannover, Germany), following his keynote presentation, to continue the discussion around COVID-19 management, current vaccine approaches and promising agents in clinical development. Questions 1. What are the major obstacles to be overcome in the investigation of management and preventative strategies for COVID-19? (0:37) […]

FILTER YOUR SEARCH

Speciality:

ERS Highlights

Michael Wechsler, ERS 2020 – Dupilumab in the LIBERTY ASTHMA TRAVERSE Trial

Ivan Gentile, ERS 2020 – Outcome Prediction in COVID-19 Patients

Sara De Matteis, ERS 2020 – Air Pollution and COVID-19 Mortality

Filippos Filippidis, ERS 2020 – Smoking as a Risk Factor for COVID-19 Infection and Severe Disease

Richard van Zyl-Smit, ERS 2020 – Optimising Inhaled Therapies for Asthma

Vasileios Kouranos, ERS 2020 – Management of Cardiac Sarcoidosis

Peter J Barnes, ERS 2020 – Smart Inhalers for COPD and Asthma

Liam Heaney, ERS 2020 – Corticosteroid Optimisation using Composite Biomarkers

Tobias Welte, ERS 2020 – COVID-19 Vaccines and Early Trials

Journal articles and more to your inbox